Ann: Following Extension of Survival, PAA Prepares Phase 3 Trial, page-18

I dont call this progress just more spin, where is the planning to move to phase 111, where are they at with contacting global pharmaceutical companies to seek partners to co-develop and commercialise MPL for treatment of veterinary cancers, have they had discussions with the animal healthcare companies from US and Germany that they reported had approached them, as reported on 28 June 2021.
And what is the reason for using liquid filled capsule which they claimed were not good enough due to issues and required the tablet formulation.
It looks more like just time wasting to me.
It time that Richard stopped telling us what an exciting time it is for PAA which he has been saying for years.
Above is all my opinion and others may see it different.